- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
Zevra Therapeutics (ZVRA)
Company Profile
| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 54.44 mm | 54.44 mm | 54.44 mm | 54.44 mm | 54.44 mm | 54.44 mm |
| Cash burn (monthly) | (no burn) | (no burn) | (no burn) | (no burn) | (no burn) | 1.95 mm |
| Cash used (since last report) | n/a | n/a | n/a | n/a | n/a | 4.86 mm |
| Cash remaining | n/a | n/a | n/a | n/a | n/a | 49.58 mm |
| Runway (months of cash) | n/a | n/a | n/a | n/a | n/a | 25.5 |
| 13F holders | Current |
|---|---|
| Total holders | 114 |
| Opened positions | 26 |
| Closed positions | 23 |
| Increased positions | 41 |
| Reduced positions | 17 |
| 13F shares | Current |
|---|---|
| Total value | 276.32 bn |
| Total shares | 38.48 mm |
| Total puts | 24.10 k |
| Total calls | 283.80 k |
| Total put/call ratio | 0.1 |
| Largest owners | Shares | Value |
|---|---|---|
| Woodline Partners | 4.14 mm | $34.52 bn |
| BlackRock | 4.08 mm | $34.03 bn |
| Adage Capital Partners GP, L.L.C. | 3.65 mm | $30.44 bn |
| Adage Capital Management | 3.65 mm | $29.27 mm |
| Vanguard | 2.82 mm | $23.55 bn |
| Nantahala Capital Management | 2.34 mm | $19.52 bn |
| FMR | 2.33 mm | $19.43 bn |
| Altium Capital Management | 1.85 mm | $15.43 bn |
| 683 Capital Management | 1.23 mm | $10.22 bn |
| Geode Capital Management | 1.19 mm | $9.91 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 2 Dec 25 | Alicia Secor | Stock Option Common Stock | Grant | Acquire A | No | No | 8.17 | 45,000 | 367.65 k | 45,000 |
| 10 Oct 25 | McFarlane Neil F. | Common Stock | Sell | Dispose S | No | Yes | 10.8158 | 19,500 | 210.91 k | 222,016 |
| 10 Oct 25 | McFarlane Neil F. | Common Stock | Option exercise | Acquire M | No | No | 0 | 50,000 | 0.00 | 241,516 |
| 10 Oct 25 | McFarlane Neil F. | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 50,000 | 0.00 | 100,000 |
| 12 Sep 25 | Alvin Shih | Common Stock | Buy | Acquire P | No | No | 7.89 | 20,000 | 157.80 k | 20,000 |
| 12 Sep 25 | Tamara A Seymour | Common Stock | Buy | Acquire P | No | No | 7.7852 | 3,175 | 24.72 k | 3,894 |